| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 09/19/2002 | US20020132796 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
| 09/19/2002 | US20020132795 Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds |
| 09/19/2002 | US20020132018 Use of non-alkalized cocoa solids in a drink |
| 09/19/2002 | US20020131940 Carotenoid preparation |
| 09/19/2002 | CA2438164A1 Use of preparations containing selenite or selenate |
| 09/18/2002 | EP1241176A1 Purine derivatives for the treatment of ischemia |
| 09/18/2002 | EP1240171A1 Cyclopenteneone derivatives |
| 09/18/2002 | EP1239826A2 Cosmetic and/or pharmaceutical preparations |
| 09/18/2002 | EP1239825A1 Catechol oximes and their use in cosmetic and dermatological preparations |
| 09/18/2002 | CN1370241A Process for producing Lycopen |
| 09/18/2002 | CN1370073A Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 09/18/2002 | CN1369214A Universal detoxicant |
| 09/18/2002 | CN1090969C Fatigue relieving medicine for driver |
| 09/17/2002 | US6451853 Small molecules that elicit a polarized Th1 response and for modulation of cellular immunity |
| 09/17/2002 | US6451849 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 09/17/2002 | US6451801 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/16/2002 | CA2376738A1 Purine derivatives for the treatment of ischemia |
| 09/12/2002 | WO2002070524A2 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 09/12/2002 | WO2002070502A1 Dimeric isoflavones |
| 09/12/2002 | WO2002069892A2 METHOD FOR PROTECTING CELLS AND TISSUES FROM IONIZING RADIATION TOXICITY WITH α, β UNSATURATED ARYL SULFONES |
| 09/12/2002 | WO2002044187A3 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 09/12/2002 | WO2001089520A3 Dehydroascorbic acid formulations and uses thereof |
| 09/12/2002 | WO2001010901A9 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 09/12/2002 | US20020128180 Purification method |
| 09/12/2002 | US20020128173 Method of treating or preventing migraine headaches |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | CA2440642A1 Dimeric isoflavones |
| 09/12/2002 | CA2439859A1 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 09/11/2002 | EP1237578A2 Micro-cluster liquids and methods of making and using them |
| 09/11/2002 | EP1237548A1 Il-8 receptor antagonists |
| 09/11/2002 | EP1237524A2 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 09/11/2002 | CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 09/11/2002 | CN1368383A Precision and preparing process of health-care compound hormone product |
| 09/11/2002 | CN1368180A Nano fleece flower root medicine and its preparing process |
| 09/10/2002 | US6448283 Fused pyrrolocarbazoles; hearing loss and loss of the sense of balance |
| 09/10/2002 | US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/10/2002 | US6448239 Porphyrin ring metallic complexes that are effective peroxynitrite decomposition catalysts for treatment of diseases involving the accumulation of this oxidant, such as altzeimer's disease |
| 09/06/2002 | WO2002068476A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | WO2002068424A1 Indole derivatives having an inhibitory effect on protein kinases |
| 09/06/2002 | WO2002067986A2 Symbiotic regenerative agent |
| 09/06/2002 | WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 09/06/2002 | WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 09/06/2002 | WO2002019972A3 Stabilized ascorbic acid solutions |
| 09/06/2002 | WO2001095937A3 Phytoestrogenic isoflavone compositions |
| 09/06/2002 | WO2001018011A9 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 09/06/2002 | CA2438238A1 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | CA2437530A1 Symbiotic regenerative agent |
| 09/05/2002 | US20020123507 Bicyclic derivatives |
| 09/05/2002 | US20020123493 For therapy and prophylaxis of neuronal damage |
| 09/05/2002 | DE10109280A1 Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen Indole derivatives having an inhibitory effect on protein kinases |
| 09/04/2002 | EP1236724A1 NEUTRALIZING AGENT FOR TOXIN OF MICROORGANISM BELONGING TO THE GENUS i CLOSTRIDIUM /i |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1049478B1 Composition containing propargylamine for enhancing cancer therapy |
| 09/04/2002 | EP0920418B1 Substituted imidazolium salts and their use for the inhibition of protein ageing |
| 09/04/2002 | EP0775143B1 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 09/04/2002 | EP0683669B1 Methods and compositions of a polymer (poloxamer) for cell repair |
| 09/04/2002 | CN1367247A Heavy metal toxinicide, its preparation method and application |
| 09/04/2002 | CN1366957A Nano Bawei Shenqi preparation medicine and preparation method |
| 09/03/2002 | US6444647 Composition comprising safe and effective amounts of vitamin b3 compound and additional skin care active selected from farnesol and/or phytantriol, and dermatologically acceptable emulsion carrier |
| 09/03/2002 | US6444144 Food, feed, drugs and cosmetics |
| 09/03/2002 | CA2128293C Fruit polyphenols and medicinal compositions containing them |
| 08/29/2002 | WO2002066668A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 08/29/2002 | WO2002066450A2 Anthrone derivatives and their use as ink inhibitors |
| 08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | WO2002065978A2 Functional agent for decomposing nicotine and method of preparing the same |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001042462A9 Phospholipase a2 inhibitory peptides from python reticulatus |
| 08/29/2002 | WO2001017530A9 Iron chelators and uses thereof |
| 08/29/2002 | US20020120098 Enhanced stimulation of erythropoiesis |
| 08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
| 08/29/2002 | US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
| 08/29/2002 | US20020119960 Drug resistance therapy |
| 08/29/2002 | CA2438312A1 Anthrone derivatives and their use as jnk inhibitors |
| 08/29/2002 | CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/28/2002 | EP1234584A1 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 08/28/2002 | EP1233962A2 Novel heterocyclic compounds and their use as medicines |
| 08/28/2002 | EP1233767A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 08/28/2002 | EP0928191B1 Pharmaceutical compositions comprising s-alkylisothiouronium derivatives |
| 08/28/2002 | EP0918759B1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 08/27/2002 | US6441168 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 08/27/2002 | US6440998 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative |
| 08/27/2002 | US6440996 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 08/22/2002 | WO2002064796A2 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/22/2002 | WO2002064110A2 Carotenoid-loaded liposomes |
| 08/22/2002 | WO2002064109A2 Mucoadhesive pharmaceutical formulations |
| 08/22/2002 | WO2002063982A1 Composition and method for smoke detoxification |
| 08/22/2002 | US20020115710 Composition and method |
| 08/22/2002 | US20020115706 Treatment of both hearing loss and loss of the sense of balance by administering a a fused pyrrolocarbazole derivative |
| 08/22/2002 | US20020114772 Methods of modulating hair growth |
| 08/22/2002 | DE10100238A1 Verfahren zur Vorhersage des Gefährdungspotentials für Karzinomerkrankungen und entzündliche Darmerkrankungen und zugehörige Tests A method for predicting the risk potential for cancer diseases and inflammatory bowel disease and related tests |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2437731A1 A medicinal composition and use comprising turmeric extract for smoke detoxification |
| 08/22/2002 | CA2437578A1 Carotenoid-loaded liposomes |
| 08/22/2002 | CA2433057A1 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use |
| 08/22/2002 | CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/21/2002 | EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |